Troponin elevation in coronary vs. non-coronary disease
S Agewall1, E Giannitsis, T Jernberg
1Department of Medicine, Oslo University Hospital and Oslo University, Oslo, Norway. stefan.agewall@medisin.uio.no
European Heart Journal
|December 21, 2010
Summary
Elevated cardiac troponin (cTn) levels indicate heart muscle injury but not always acute coronary syndrome (ACS). This review examines non-ACS conditions causing cTn elevation, aiding clinical diagnosis.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Acute myocardial infarction (AMI) involves myocardial cell death from ischemia.
- Cardiac troponins (cTn) are sensitive biomarkers for myocardial injury.
- High-sensitivity troponin assays detect minor cardiac damage.
Purpose of the Study:
- To review studies on non-acute coronary syndrome (non-ACS) patients with elevated cTn.
- To aid in differentiating cTn elevation from ACS in clinical practice.
Main Methods:
- Literature review of studies involving elevated cTn in non-ACS conditions.
- Analysis of clinical scenarios where cTn elevation mimics ACS.
Main Results:
- Elevated cTn levels occur in various conditions beyond ACS, including stroke, pulmonary embolism, sepsis, and heart failure.
- Differentiating cTn elevation causes can be challenging.
- No specific guidelines exist for treating elevated cTn without coronary disease.
Conclusions:
- Elevated cTn necessitates careful evaluation to determine the underlying cause.
- Treatment strategies focus on the primary condition causing cTn elevation.
- Further research is needed to guide management of non-ACS related cTn elevations.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...